APA
(2012). The Antiplatelet Journey Thus Far: Focus On New Oral P2Y12 Inhibitors. European Journal of Cardiovascular Medicine, 2(1), 21-30.
MLA
. "The Antiplatelet Journey Thus Far: Focus On New Oral P2Y12 Inhibitors." European Journal of Cardiovascular Medicine 2.1 (2012): 21-30.
Chicago
. "The Antiplatelet Journey Thus Far: Focus On New Oral P2Y12 Inhibitors." European Journal of Cardiovascular Medicine 2, no. 1 (2012): 21-30.
Harvard
(2012) 'The Antiplatelet Journey Thus Far: Focus On New Oral P2Y12 Inhibitors' European Journal of Cardiovascular Medicine 2(1), pp. 21-30.
Vancouver
. The Antiplatelet Journey Thus Far: Focus On New Oral P2Y12 Inhibitors. European Journal of Cardiovascular Medicine. 2012 ;2(1):21-30.